Life Bioprinted
In a highly horizontal industry such as 3D printing, the area of bioprinting can represent an entire industry. Therefore, this section in the 3D printing business directory reflects the diversity of this industrial segment. It includes 3D bioprinter hardware manufacturers, bioprinting materials (or bioinks) manufacturers as well as 3D bioprinting services and laboratories. These are often internal to Universities and are servicing the bioengineering, biofabrication and regenerative medicine sectors.

3D Bioprinting includes several different technologies. The most common is pneumatic extrusion, which combines a hydrogel material with either a polymer, ceramic or stem-cell based materials and extruded through a syringe forming complex tridimensional shapes. Other technologies for bioprinting include the use of inkjet/material jetting and stereolithography with UV curing. The most common biomaterials for 3D bioprinting today are cartilage, skin tissue, bone-like ceramic materials and some organ tissue such as liver or kidney, use mainly for drug discovery applications.

Search Results

Search Results for""
rainbow-biosciences.png
Rainbow Biosciences, LLC, a new division of Rainbow Coral Corp. (RBCC), is a new company focused on identifying, developing and marketing the next generation of bioscience solutions for physicians, researchers and pharmaceutical engineers. The company is positioned to leverage proven resources that assess, enhance and realize the commercial potential of bioscience discoveries. We are forging connections between and among local academia and industry experts to promote commercially viable research. Our new technology products are poised to deliver substantial returns to early investors.

KIMBERLY PALMER - PRESIDENT, CEO

RBCC President and CEO Kimberly Palmer is a healthcare expert in charge of implementing RBCC’s developing business strategy in the field of regenerative medicine. For the past eight years, Ms. Palmer has served as a business consultant to private surgeons, providing administrative and clinical support for a variety of medical practices. As a registered nurse, she also brings extensive experience with surgical pre- and post-operative patient care to RBCC. At RBCC, Ms. Palmer is spearheading the marketing and development of new breakthroughs in the multi-billion dollar global regenerative and precision medicine markets.
Read More
regenHU.png
regenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SA. regenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. 
Read More
n3D-biosciencesgo.png
Biomedical research is gravitating towards 3D cell culture models and tissue printing. At n3D, we sell kits and services for 3D cell culture. Our core technology is the magnetization of cells, which can then be directed using magnetic forces. In this manner, we can either levitate or bioprint cells. These cultures are faster to assemble than other systems and easier to handle with magnets without losing samples. Check out our products and our services for more information on our technology, and how we can help you! There is a growing push for biomedical and pharmaceutical research to transition towards three-dimensional (3D) cell culture models. Model selection is basically a choice between representation (animal testing) and throughput (in vitro cell culture). 3D cell culture brings the best of both worlds, but technical limitations in cost and handling have prevented its widespread use. To overcome these challenges, Nano3D Biosciences (n3D) has developed magnetic cell culture, where we magnetize cells using NanoShuttleTM-PL, and then rapidly print them into microtissues using magnetic force. This is an easy method for 3D cell culture that works with any cell type, making it ideal for biomedical research and high-throughput compound screening. We offer a wide product line for our technology with kits that are easy to use and fit seamlessly into existing cell culture workflows. We also provide services, in cell culture optimization or contract research, where we leverage our expertise in 3D cell culture to deliver quality results. At n3D, our goal is to develop our magnetic cell culture technology into the industry standard for 3D cell culture, with longer term focuses on personalized medicine and regenerative medicine.
Read More
Bio3D.png

An Emerging Tool for Science & Technology

3D printing has recently become popular because of its ease and speed to customise 3D designs and turn them into real physical objects. 3D scientific and biological printing takes it further by 3D printing living cells, tissues and other biomaterials such as bacteria, antibodies, antigens, bio-gels, medicine, food materials and bio-polymers.

Scientists and engineers around the world continue to explore and study how the arrangement and design of living cells and other bio- and non-bio materials using 2D and/or 3D bio-printing can bring great potentials and applications in fields such as research & development, diagnostics, personalised medicine and drug development and testing.


WHO WE ARE

We are a group of enthusiastic scientists, engineers and entrepreneurs coming together to bring new and disruptive technologies and sciences to the world. Bio3D Technologies is the fruit of our research and efforts, and we are proud to be one of the world's bioprinting pioneers. Together, we have created world's first and Singapore's first true scientific and biological 3D printer with multiple print heads, modular design, nozzle-to-platform auto-alignment, remote viewing and control etc. We are also the first to integrate an anti-vibration levitating platform into a 3D printer. We hope to bring affordable and reliable bioprinting and microprinting technologies to every researcher and engineer for the advancement of science and technology. With the introduction of Bio3D Explorer, we made 3D bioprinting even more affordable and accessible. Once again, we created another world's first- a foldable bioprinter that can be transported around easily.
Read More
3dynamic.png
3Dynamic Systems is a Swansea University UK-based 3D-Bioprinting manufacturer offering the first commercial and affordable 3D-Bioprinting systems. Our 3D-Bioprinters stem from our teams success in engineering tissues using Bioprinting technology. Our aim is to bring affordable and reliable bioprinting technologies to scientists and engineers who carry out research in the field of tissue engineering. Researchers from across the world wanted a flexible 3D-Bioprinter that was easy to install, operate and which offers value for money. This is what we have produced, accessible 3D bioprinting technology. Now you can procure this technology. Every machine is made to order using the same high quality materials and precise control systems, which is based on years of research and development. Every system is made to the same high tolerances that we have aspired to since day one. With a durable steel superstructure our machines are built to last. Our Alpha and Omega 3D-Bioprinters are dynamic, adaptive and durable technologies which are easy to use, repeatable and precisely deposit biological materials in 3D. The ability to engineer 3D tissue systems gives researchers in the field a tool to perform repeatable research into the sphere of 3D-Bioprinting. Be it if you are working with stem cell systems, cancer research, antibodies, proteins and/or bacteria research. Our systems can aid you in depositing materials accurately and efficiency in 3D.
Read More
aspect-biosystems.png
Aspect Biosystems is a privately held biotechnology company combining the power of microfluidics and 3D bioprinting to fuel medical research and the development of bioprinted therapeutics. By adopting Aspect’s microfluidic 3D bioprinting platform and collaborating within Aspect’s network, researchers worldwide are accelerating the development and commercialization of 3D bioprinted tissues. In addition, Aspect is advancing its internal regenerative medicine programs focused on metabolic diseases and musculoskeletal injuries and disorders and partnering with key industry players to bring bioprinted therapeutics to the clinic.
Read More
innoTERE.jpg
In 2004, InnoTERE was founded by Dr. Berthold Nies and took up its business in Dresden in 2005. As a result of our growth we moved to Pharmapark Radebeul at 1st January 2012. Since 2014 Erich Roethlisberger is our second Managing Director in the areas of marketing and sales. Long-standing experiences in industrial research and development of biomaterials as well as the location in Dresden with its competences in materials science and biomaterials are solid basements for successful development of innovative products for bone tissue regeneration. As an innovative company, we have set ourselves the target to explore, develop and produce in close collaboration with researchers and clinicians new products for the treatment of bone damage and finally market as medical devices. One of our development priorities form novel bone cements on the basis of calcium phosphates and polymers. These bone cements enable a minimally invasive treatment of bone defects. We join together team members and cooperation partners who share our vision of innovative biomaterials for the well-being of affected patients. We further the creativity and skills of our team members and encourage their willingness to cooperate with interdisciplinary partners. InnoTERE is a founding member of the innovation incentive "Molecular Designed Biological Coating" (MBC) promoted by the Federal Ministry of Education and Research (BMBF) lasting from 2007 to 2010, which was awarded "Selected Landmark 2008 in the Land of Ideas" In 2008 InnoTERE was successfully certificated EN ISO 9001:2008 and EN ISO 13485:2012 in the scope of design/development, manufacturing and distribution of bone implants, bone cements and bone substitute materials.
Read More
Xilloc.jpg
At Xilloc, we believe that engineering and technology can be used even more in healthcare for the benefit of individual patients. “Personalized medicine” is a term often coined. We feel however, that this is not yet applied to implants and prosthetics, as these are mostly standard products, sometimes modified for an improved fit. Everybody is different and unique and therefore the human body and a patient’s anatomy should be the starting point for the design and engineering of individual implants and prosthetics. We feel that we can bridge the gap between the physician and individually engineered products. As such we aim to provide Patient Specific implants to reconstruct parts of the human’s skeleton.
Read More
ooster.png
RoosterBio is a products and technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time. RoosterBio’s products are high volume, affordable, and well-characterized adult mesenchymal stem cells (MSCs) with highly engineered media systems.  RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to time and costs savings for customers.  Our innovative products are ushering in a new era of productivity and standardization into the field (as seen by customer product reviews), and researchers spend new found time & money performing more high-value experiments, accelerating the road to discovery in Regenerative Medicine. RoosterBio's dedicated team has relevant technical, operational and regulatory experience and are considered leaders in the fields of Bio-manufacturing and Regenerative Medicine.  The team has over 20 years of experience with the major cell and media supply companies including BD, Thermo Fisher (Life Technologies) and Lonza. The team are experts in cell and tissue technology, and have an intimate understanding of the cell supply needs of the industry. RoosterBio leads the field of new-thinkers in stem cell research, cell and tissue engineering, and the commercialization of regenerative and biofabrication technologies.   RoosterBio can be followed on our highly regarded blog Democratizing Cell Technologies.
Read More
images.jpg
Mission MERLN aims to maintain a leading position in the field of biomedical engineering by combining creative research with training of a generation of interdisciplinary scientists. MERLN’s activities operate at the interface of biology and engineering and we aim to maximize outreach at the level of public involvement, development and commercialization of research. MERLN’s vision is based on sharing of knowledge, infrastructure and ambition. Research Research at MERLN is focused on developing novel and breakthough technologies to advance the field of repair and regeneration of both tissues and functional organs. The strategy includes, amongst others, the development of “smart” biomaterials which can trigger intrinsic tissue repair mechanisms mediated by the patient’s own cells. Education MERLN’s scientists will be involved in educational activities within different undergraduate and graduate programmes. Our expertise lies in biology, chemistry, materials science and engineering, with a distinct emphasis on biomedical applications, including regenerative medicine. Collaboration Scientists at MERLN have an extensive network of collaborators within research institutions in and outside the Netherlands as well as with a number of biomedical companies, including their own spin-off companies. Newly situated in a hospital setting, close collaboration with medical experts will expedite the testing and use of our technoligies in a clinically relevant setting.
Read More
regenovo
The recently announced Regenovo is the latest in a line of medical grade 3D bioprinters that is still under development and showing promising results. Coming out of the Hanghou University of Science and Technology in the eastern Zhejiang Province of China, the Regonovo has already produced numerous gelatinous, semi-transparent 3D printed ears, kidneys and various other conglomerations of cells in sterile environments. The printer uses medical polymers, live cells, inorganic and hydrogel materials to create a scaffold from which cells are cultured to create living tissue.
Read More
ebers1.png
EBERS develops, manufactures and commercializes devices for research in cell culture, with special emphasis in the field of bioreactors and culture chambers for tissue engineering. Such bioreactors try to reproduce in an in-vitro culture environment some of the conditions which cells experience when growing in-vivo by using two different approaches: the application of controlled flow rates or the direct deformation of the scaffolds in which cells are seeded. The TEB series bioreactors allows applying a wide variety of flow profiles on the cultures. Used in combination with any of the available EBERS culture chambers, it allows creating both perfusion and perifusion conditions to culture cells on porous bone-type scaffolds as well as on cylindrical vessel-type scaffolds. The TC-3 bioreactor allows applying direct compression on the scaffolds to simulate in the culture the deformation occurring in the in-vivo tissues. Tension and compression can be alternatively applied to simulate the growing conditions in ligament, tendon or bone scaffolds. Moreover, our experienced engineering offers a consultancy service for the adaptation bioreactors and culture chambers to the particular demands of each researcher. As a crucial part of the company's strategy, we currently continue developing new systems for cell culture. We kindly invite you to surf our web for information on our products or to contact us for more specific information!  
Read More
isbf-lg-150×150.png
The International Society for Biofabrication (ISBF) was founded in 2010 and is a scientific and professional Society, which promotes advances in Biofabrication research, development, education, training, and medical and clinical applications. The ISBF represents the international Biofabrication community and operates as a non-profit organization. The ISBF’s core purpose is to foster scientific and technological innovation and excellence for the benefit of humanity. ISBF promotes the interaction between and convergence in the different disciplines of the field of Biofabrication, as well as between basic research and applied practice. Further, the Society aims to promote the cooperation with other scientific organizations and communities.
Read More
Allevi
Allevi, formerly known as BioBots is the 3D printer for biology. We are eliminating the organ waiting list to save tens of thousands of lives very year. We do this by building 3D bioprinter & accompanying printer cartridges that are accessible to both researchers at the frontier of regenerative medicine and non-specialists, such as high school biology teachers. By making this technology available and creating a community of users, we are lowering the barrier to entry into the field of regenerative medicine injecting a new dose of innovation into health care.
Read More
regemat.png
REGEMAT 3D is a biotech company focused on regenerative medicine and pioneer in a new and promising area called bioprinting, that uses 3D printing technologies for regenerative therapies. We provide bioprinting solutions for the community. We will support you to generate IP. We promote the creation of an open community to boost the clinical applications of bioprinting.
Read More
bioverse+
Bioverse is the first online platform for sharing of 3D models for 3D Bioprinting. To access the community, simply sign up for the beta membership. The best part is that it's completely free if you sign up now!
Read More
The-3D-Printing-Store.png
The 3D Printing Store opened in Denver, Colorado in November, 2012. Co-founders Debra Wilcox and Kenton Kuhn decided that 3D printing was a cool technology, well-known to engineers, but not readily available to the public. The idea of a bricks and mortar store seemed to be the best way to make this a consumer facing reality. With a growing list of customers, The 3D Printing Store has quickly become the place to Print Your Ideas®.
Read More
Trimaker.png
"Trimaker is a company specializing in 3D printing. We create technology and tools that will change how things are created and builded in the future. We are facing a new paradigm of production and we are the protagonists of this era of digital fabrication. We are part of a new way of creating and materializing ideas. From design and art, to the manufacturing of prototyping parts at industrial level. "
Read More
nanoscribe_logo_screen_nanoblue_72ppi
Nanoscribe GmbH, located in Eggenstein-Leopoldshafen near Karlsruhe, Germany, offers 3D printers for the micro- and nanometer scale as well as photoresists and process solutions tailored to specific application areas.
Read More
Roslin-Cellab.png
Roslin Cellab is a stem cell technology company, providing contract research, product development work and stem cell culture training for academic and commercial clients in the life science, biotechnology and pharmaceutical sectors. We provide you with the opportunity to explore and exploit stem cell biology and regenerative medicine. Our expert scientists come from Edinburgh University’s MRC Centre for Regenerative Medicine and the Roslin Institute and have many years experience of deriving, culturing and manipulating human stem cells in wide range of culture systems.
Read More

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec_
  • wp-settings-
  • wp-settings-time-

Decline all Services
Accept all Services

This information will not be shared with third parties